Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Javanshir, Shahrzad  [Clear All Filters]
2024
Ghomi MKhalili, Noori M, Mirahmad M, Iraji A, Sadr AShahir, Dastyafteh N, Asili P, Gholami M, Javanshir S, Lotfi M, et al. Evaluation of novel 2-(quinoline-2-ylthio)acetamide derivatives linked to diphenyl-imidazole as α-glucosidase inhibitors: Insights from in silico, in vitro, and in vivo studies on their anti-diabetic properties. Eur J Med Chem. 2024;269:116332.
2023
Ghomi MKhalili, Noori M, Montazer MNazari, Zomorodian K, Dastyafteh N, Yazdanpanah S, Sayahi MHosein, Javanshir S, Nouri A, Asadi M, et al. [1,2,4]triazolo[3,4-b][1,3,4]thiadiazole derivatives as new therapeutic candidates against urease positive microorganisms: design, synthesis, pharmacological evaluations, and in silico studies. Sci Rep. 2023;13(1):10136.
Dastyafteh N, Noori M, Montazer MNazari, Zomorodian K, Yazdanpanah S, Iraji A, Ghomi MKhalili, Javanshir S, Asadi M, Dianatpour M, et al. New thioxothiazolidinyl-acetamides derivatives as potent urease inhibitors: design, synthesis, in vitro inhibition, and molecular dynamic simulation. Sci Rep. 2023;13(1):21.
Noori M, Dastyafteh N, Safapoor S, Ghomi MKhalili, Tanideh R, Zomorian K, Hamedifar H, Dara M, Zare S, Irajie C, et al. Phenyl-quinoline derivatives as a lead structure of cholinesterase inhibitor endowed with potency to reduce the GSK-3β level targeting Alzheimer's disease. Int J Biol Macromol. 2023:127392.
Forozan RD, Ghomi MKhalili, Iraji A, Montazer MNazari, Noori M, Dastyafteh N, Mojtabavi S, Faramarzi MAli, Sadat-Ebrahimi SEsmaeil, Larijani B, et al. Synthesis, in vitro inhibitor screening, structure-activity relationship, and molecular dynamic simulation studies of novel thioquinoline derivatives as potent α-glucosidase inhibitors. Sci Rep. 2023;13(1):7819.